Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours

European Journal of Nuclear Medicine

Volumn 25, Issue 10, 1998, Pages 1396-1403

  Chiti, Arturo ^a   Fanti, Stefano ^b   Savelli, Giordano ^a   Romeo, Annadina ^b   Bellanova, Bartolomeo ^b   Rodari, Marcello ^a   Van Graafeiland, Barbara J ^c   Monetti, Nino ^b   Bombardieri, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gastro entero pancreatic tract; Neuroendocrine tumours; Radionuclide imaging; Somatostatin receptors

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIGESTIVE SYSTEM TUMOR; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROENDOCRINE TUMOR; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; WHOLE-BODY COUNTING;

EID: 0031718157     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050314     Document Type: Article

References (20)

1. Oberg K. Neuroendocrine gastrointestinal tumours. Ann Oncol 1996; 7: 453-463.
2. Solcia E, Capella C, Buffa R. Cytology of tumours in the gastroenteropancreatic and diffuse neuroendocrine system. In: Falkmer S, Akanson S, Sundler F, eds. Cytology of tumours of the neuroendocrine system. Amsterdam: Elsevier; 1984: 453-480.
3. Solcia E, Rindi G, Sessa F, Fiocca R, Luinetti O, Bosi F. Endocrine tumours of the gastrointestinal tract. In: Polak JM, ed. Diagnostic histopathology of neuroendocrine tumours. Edinburgh: Churchill Livingstone; 1993: 123-149.
4. Williams ED, Sandler M. The classification of carcinoid tumours. Lancet 1963; I: 238-239.
5. Seregni E, Chiti A, Bombardieri E. Radionuclide imaging of neuroendocrine tumors: biological basis and diagnostic results. Eur J Nucl Med 1998; 25: 639-658.
6. Lamberts SWJ, Reubi JC, Krenning EP. Somatostatin and the concept of peptide receptor scintigraphy in oncology. Semin Oncol 1994; 21(Suppl 13): 1-5.
7. Krenning EP, Kwekkeboom DJ, de Jong M, Visser TJ, Reubi JC, Bakker WH, Kooij PP, Lamberts SW. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide. Semin Oncol 1994; 21(Suppl 13): 6-14.
8. 111In-pentetreotide for endocrine gastroenteropancreatic tumors. Horm Metab Res 1993; 27(Suppl): 28-35.
9. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
10. 1]-octreotide. Acta Oncol 1998; 32: 783-788.
11. 1]-octreotide. Q J Med 1994; 87: 83-87.
12. Modlin IM, Cornelius E, Lawton GP. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors. Arch Surg 1995; 130: 367-374.
13. Schillaci O, Scopinaro F, Angeletti S, Tavolaro R, Danieli R, Annibale B, Gualdi G, Delle Fave G. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors. J Nucl Med 1996; 37: 1452-1456.
14. Jamar F, Fiasse R, Leners N, Pauwels S. Somatostatin receptor imaging with indium-111-pentetreotide in gastroentero-pancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J Nucl Med 1995; 36: 542-549.
15. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PP, Lamberts SW. Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 1993; 20: 283-292.
16. Lamberts SWJ, Reubi JC, Krenning EP. Somatostatin and the concept of peptide receptor scintigraphy in oncology. Semin Oncol 1994; 21(Suppl 13): 1-5.
17. Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y, Mignon N, Le Guludec D. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med 1997; 38: 853-858.
18. Kälkner KM, Janson ET, Nilsson S, Carlsson S, Oberg K, Westlin JE. Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers. Cancer Res 1995; 55(Suppl): 5801s-5804s.
19. Soresi E, Bombardieri E, Chiti A, Boffi R, Invernizzi G, Crippa F, Maffioli L. Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in small-cell lung cancer. Tumori 1995; 81: 125-127.
20. Dörr U, Räth U, Sautter-Bihl ML, Guzman G, Bach D, Adrian HJ, Bihl H. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue. Eur J Nucl Med 1993; 20: 431-433.